Anti FGF23 antibody and a pharmaceutical composition comprising the same
US9290569B2 · kind B2 · utility
0Cited by
9References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2011 |
| Grant date | Mar 22, 2016 |
| Priority date | — |
| Expiry date | Dec 21, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
To provide an antibody against FGF23 and a pharmaceutical composition such as a preventive or therapeutic agent which can prevent or treat by suppressing an action of FGF23 by using the antibody. An antibody or its functional fragment against human FGF23 produced by hybridoma C10 (Accession No. FERM BP-10772).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.